Omar Laterza

4.3k total citations · 1 hit paper
58 papers, 2.3k citations indexed

About

Omar Laterza is a scholar working on Molecular Biology, Physiology and Spectroscopy. According to data from OpenAlex, Omar Laterza has authored 58 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Physiology and 10 papers in Spectroscopy. Recurrent topics in Omar Laterza's work include Advanced Proteomics Techniques and Applications (10 papers), Alzheimer's disease research and treatments (8 papers) and Mass Spectrometry Techniques and Applications (6 papers). Omar Laterza is often cited by papers focused on Advanced Proteomics Techniques and Applications (10 papers), Alzheimer's disease research and treatments (8 papers) and Mass Spectrometry Techniques and Applications (6 papers). Omar Laterza collaborates with scholars based in United States, United Kingdom and Switzerland. Omar Laterza's co-authors include Mitchell G. Scott, Christopher P. Price, Philip W. Garrett-Engele, Wesley Tanaka, Jason M. Johnson, Joseph F. Sina, Kateřina Vlasáková, Thomas L. Fare, Frank D. Sistare and Lee P. Lim and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and Analytical Biochemistry.

In The Last Decade

Omar Laterza

58 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cystatin C: An Improved Estimator of Glomerular Filtration Rate?

2002 509 citations Omar Laterza, Mitchell G. Scott et al. Clinical Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Omar Laterza United States	23	933	532	404	373	258	58	2.3k
Sumita Sinha United States	19	895 1.0×	256 0.5×	275 0.7×	291 0.8×	228 0.9×	25	2.0k
Eiji Kubota Japan	28	877 0.9×	176 0.3×	317 0.8×	273 0.7×	574 2.2×	133	2.9k
Didier Portilla United States	34	1.7k 1.9×	592 1.1×	1.6k 3.9×	237 0.6×	281 1.1×	68	4.0k
Clara E. Magyar United States	29	1.5k 1.6×	296 0.6×	228 0.6×	282 0.8×	181 0.7×	66	2.5k
James M. Luther United States	31	757 0.8×	231 0.4×	146 0.4×	240 0.6×	556 2.2×	71	2.7k
Hideaki Yoshida Japan	30	1.3k 1.4×	165 0.3×	249 0.6×	278 0.7×	581 2.3×	116	2.8k
Maura Brioschi Italy	29	818 0.9×	361 0.7×	59 0.1×	189 0.5×	381 1.5×	75	1.9k
Soumeya Bekri France	29	1.2k 1.3×	208 0.4×	84 0.2×	788 2.1×	87 0.3×	124	3.4k
Joseph P. Gaut United States	29	1.1k 1.2×	132 0.2×	664 1.6×	431 1.2×	162 0.6×	72	3.3k
Hans‐Ulrich Häring Germany	27	1.2k 1.3×	166 0.3×	78 0.2×	502 1.3×	261 1.0×	46	2.8k

Countries citing papers authored by Omar Laterza

Since Specialization

Citations

This map shows the geographic impact of Omar Laterza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Laterza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Laterza more than expected).

Fields of papers citing papers by Omar Laterza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Laterza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Laterza. The network helps show where Omar Laterza may publish in the future.

Co-authorship network of co-authors of Omar Laterza

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Laterza. A scholar is included among the top collaborators of Omar Laterza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Laterza. Omar Laterza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Ping, Christian Poehlein, Matthew J. Marton, Omar Laterza, & Diane Levitan. (2019). Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS Assays. Scientific Reports. 9(1). 114–114. 41 indexed citations

Zhao, Xuemei, Vladimir Svetnik, Donald Warden, et al.. (2019). A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease. The Journal of Applied Laboratory Medicine. 5(1). 15–28. 20 indexed citations

Lassman, Michael E., et al.. (2016). The clinical utility of mass spectrometry based protein assays. Clinica Chimica Acta. 459. 155–161. 10 indexed citations

Zhao, Xuemei, Liliana Delgado, Russell Weiner, & Omar Laterza. (2015). Influence of Pre-Analytical Factors on Thymus- and Activation-Regulated Chemokine Quantitation in Plasma. PubMed. 4. 10–10. 4 indexed citations

Zhao, Xuemei, Gulesi Ayanoglu, Laurence Fayadat‐Dilman, et al.. (2015). A Clinical Biomarker Assay to Quantitate Thymic Stromal Lymphopoietin in Human Plasma at Sub-Pg/Ml Level. Bioanalysis. 7(5). 573–582. 3 indexed citations

Lassman, Michael E., Thomas McAvoy, Anita Y. H. Lee, et al.. (2014). Practical Immunoaffinity-Enrichment LC-MS for Measuring Protein Kinetics of Low-Abundance Proteins. Clinical Chemistry. 60(9). 1217–1224. 29 indexed citations

Santoro, Joseph C., et al.. (2013). Quantitative determination of human interleukin 22 (IL-22) in serum using Singulex-Erenna® Technology. Journal of Immunological Methods. 390(1-2). 30–34. 14 indexed citations

Williams, Jonathan H., Gordon Wilcock, Jeffrey L. Seeburger, et al.. (2011). Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study. Alzheimer s Research & Therapy. 3(1). 5–5. 19 indexed citations

Green, Stuart, et al.. (2010). Quantitative measurement of cysteinyl leukotrienes and leukotriene B4 in human sputum using ultra high pressure liquid chromatography–tandem mass spectrometry. Journal of Chromatography B. 879(3-4). 277–284. 18 indexed citations

10.

Lauring, Brett, Victor Dishy, Wen‐Lin Luo, et al.. (2009). Laropiprant in Combination With Extended‐Release Niacin Does Not Alter Urine 11‐Dehydrothromboxane B₂, a Marker of In Vivo Platelet Function, in Healthy, Hypercholesterolemic, and Diabetic Subjects. The Journal of Clinical Pharmacology. 49(12). 1426–1435. 12 indexed citations

11.

Schwartz, Jules I., Aimée Dallob, Patrick Larson, et al.. (2008). Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX‐2 Versus COX‐1 in Healthy Subjects. The Journal of Clinical Pharmacology. 48(6). 745–754. 35 indexed citations

12.

Eveland, Suzanne S., Denise P. Milot, Qiu Guo, et al.. (2007). A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology. Analytical Biochemistry. 368(2). 239–249. 13 indexed citations

13.

Laterza, Omar, Vijay Modur, Dan L. Crimmins, et al.. (2006). Identification of Novel Brain Biomarkers. Clinical Chemistry. 52(9). 1713–1721. 96 indexed citations

14.

Cameron, Scott J., Gary B. Green, Craig White, et al.. (2005). Assessment of BNP and NT-proBNP in emergency department patients presenting with suspected acute coronary syndromes. Clinical Biochemistry. 39(1). 11–18. 17 indexed citations

15.

Laterza, Omar, Scott J. Cameron, Derek L Chappell, Lori J. Sokoll, & Gary B. Green. (2004). Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clinica Chimica Acta. 348(1-2). 163–169. 38 indexed citations

16.

Laterza, Omar, et al.. (2003). Unusually high concentrations of cTnI and cTnT in a patient with catastrophic antiphospholipid antibody syndrome. Clinica Chimica Acta. 337(1-2). 173–176. 8 indexed citations

17.

Laterza, Omar, et al.. (2002). Accurate direct spectrophotometric bilirubin measurement combined with blood gas analysis. Clinica Chimica Acta. 323(1-2). 115–120. 15 indexed citations

18.

Laterza, Omar & Norman P. Curthoys. (2000). Effect of Acidosis on the Properties of the Glutaminase mRNA pH-Response Element Binding Protein. Journal of the American Society of Nephrology. 11(9). 1583–1588. 16 indexed citations

19.

Covinsky, Michael, Omar Laterza, John D. Pfeifer, Tünde Farkas-Szallasi, & Mitchell G. Scott. (2000). An IgM λ Antibody to Escherichia coli Produces False-Positive Results in Multiple Immunometric Assays. Clinical Chemistry. 46(8). 1157–1161. 41 indexed citations

20.

Laterza, Omar, et al.. (1997). Identification of an mRNA-binding Protein and the Specific Elements That May Mediate the pH-responsive Induction of Renal Glutaminase mRNA. Journal of Biological Chemistry. 272(36). 22481–22488. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact